PF2401-SF

from Salvia miltiorrhiza; structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Liver Cirrhosis (Hepatic Cirrhosis) 02/06/2013 - "Our data suggest that PF2401-SF can mediate HSCs apoptosis induction, and may be a potential herbal medicine for the treatment of liver fibrosis." 04/01/2015 - "Anti-fibrotic effect of PF2401-SF, a standardized fraction of Salvia miltiorrhiza, in thioacetamide-induced experimental rats liver fibrosis." 04/01/2015 - "The aim of this study was to investigate the effect of PF2401-SF on liver fibrosis induced by thioacetamide (TAA), a chronic liver injury model (12 weeks) that closely resembles fibrosis and cirrhosis in humans. "
2.	Fibrosis (Cirrhosis) 04/01/2015 - "The aim of this study was to investigate the effect of PF2401-SF on liver fibrosis induced by thioacetamide (TAA), a chronic liver injury model (12 weeks) that closely resembles fibrosis and cirrhosis in humans. "
3.	Inflammation (Inflammations) 06/01/2013 - "Moreover, we also evaluated that PF2401-SF significantly reduced inflammation on carrageenan- or dextran-induced acute arthritis in rats. "
4.	Arthritis (Polyarthritis) 06/01/2013 - "PF2401-SF, standardized fraction of Salvia miltiorrhiza shows anti-inflammatory activity in macrophages and acute arthritis in vivo." 06/01/2013 - "Moreover, we also evaluated that PF2401-SF significantly reduced inflammation on carrageenan- or dextran-induced acute arthritis in rats. "

1.	Thioacetamide (Thioacetamid)
2.	Dextrans (Dextran)
3.	Carrageenan